Advertisement
Screener

NEUMORA THERAPEUTICS, INC. (NMRA) Patents: Active

NEUMORA THERAPEUTICS, INC. Active Patents

15 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2025-02-19: Application 19057860; Invention PREDICTING THE OUTCOME OF A CLINICAL TRIAL USING A MACHINE LEARNING MODEL; Applicant NEUMORA THERAPEUTICS, INC.; Status Patented Case.
  • 2024-07-03: Application 18764004; Invention CRYSTALLINE SALT FORMS OF KAPPA OPIOID RECEPTOR ANTAGONIST AND PRODUCTS AND METHODS RELATED THERETO; Applicant Neumora Therapeutics, Inc.; Status Patented Case.
  • 2024-04-05: Application 18628594; Invention METHODS OF TREATING NEUROLOGICAL DISORDERS; Applicant NEUMORA THERAPEUTICS, INC.; Status Patented Case.
  • 2023-12-01: Application 18526960; Invention METHODS OF TREATING NEUROLOGICAL DISORDERS; Applicant NEUMORA THERAPEUTICS, INC.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2025-02-1919057860PREDICTING THE OUTCOME OF A CLINICAL TRIAL USING A MACHINE LEARNING MODELNEUMORA THERAPEUTICS, INC.Patented Case2026-09-0812731692
Tathagata Banerjee
Karin Comer Knudson
United States
United States
HAMILTON, MATTHEW L
2024-07-0318764004CRYSTALLINE SALT FORMS OF KAPPA OPIOID RECEPTOR ANTAGONIST AND PRODUCTS AND METHODS RELATED THERETONeumora Therapeutics, Inc.Patented Case2024-12-2412171758
Brian Van Dyke
Yawei Shi
Mengya Ma
Lori Jean Van Orden
United States
United States
China
United States
HABTE, KAHSAY
2024-04-0518628594METHODS OF TREATING NEUROLOGICAL DISORDERSNEUMORA THERAPEUTICS, INC.Patented Case2025-07-2912371414US20240294492A1
Paul Dransfield
Dilinie Fernando
James Harvey
Brian Sparling
John Stellwagen
Zhihua Ma
Anne-Marie Beausoleil
Ryan Hudson
United States
United States
United States
United States
United States
United States
United States
United States
SEAMAN, D MARGARET M
2023-12-0118526960METHODS OF TREATING NEUROLOGICAL DISORDERSNEUMORA THERAPEUTICS, INC.Patented Case2024-05-2811993580US20240246928A1
Paul Dransfield
Dilinie Fernando
James Harvey
Brian Sparling
John Stellwagen
Zhihua Ma
Anne-Marie Beausoleil
Ryan Hudson
United States
United States
United States
United States
United States
United States
United States
United States
SEAMAN, D MARGARET M
2023-05-0218311087MACHINE LEARNING-BASED DIAGNOSTIC CLASSIFIERNEUMORA THERAPEUTICS, INC.Patented Case2024-06-0412002590US20230343463A1
Monika Sharma MELLEM
Yuelu LIU
Parvez AHAMMAD
Humberto Andres GONZALEZ CABEZAS
William J. MARTIN
Pablo Christian GERSBERG
United States
United States
United States
United States
United States
United States
TOMASZEWSKI, MICHAEL
2022-10-0517960759ESTIMATING UNCERTAINTY IN PREDICTIONS GENERATED BY MACHINE LEARNING MODELSNEUMORA THERAPEUTICS, INC.Patented Case2024-01-3011887724US20230109108A1
Tathagata Banerjee
Matthew Edward Kollada
Amirsina Torfi
Peter Crocker
United States
United States
United States
United States
ELSHAER, ALAAELDIN M
2022-10-0517960755MACHINE LEARNING SYSTEMS FOR GENERATING MULTI-MODAL DATA ARCHETYPESNEUMORA THERAPEUTICS, INC.Patented Case2023-08-2911742076US20230107415A1
Tathagata Banerjee
Matthew Edward Kollada
United States
United States
RYLANDER, BART I
2022-10-0517960744MACHINE LEARNING SYSTEMS FOR TRAINING ENCODER AND DECODER NEURAL NETWORKSNEUMORA THERAPEUTICS, INC.Patented Case2023-10-2411798681US20230104158A1
Tathagata Banerjee
Matthew Edward Kollada
United States
United States
RYLANDER, BART I
2022-10-0517960705MACHINE LEARNING SYSTEMS FOR PROCESSING MULTI-MODAL PATIENT DATANEUMORA THERAPEUTICS, INC.Patented Case2023-06-0611670417US20230105659A1
Tathagata Banerjee
Matthew Edward Kollada
United States
United States
COLE, BRANDON S
2022-05-1017740713MULTIMODAL DYNAMIC ATTENTION FUSIONNEUMORA THERAPEUTICS, INC.Patented Case2024-09-1012087446US20220392637A1
Matthew Kollada
Tathagata Banerjee
United States
United States
NG, JONATHAN K
2021-10-1417603779SYSTEM AND METHOD OF FACIAL ANALYSISNeumora Therapeutics, Inc.Patented Case2025-02-2512232848US20220101655A1
John Chan
Sandeep R. Datta
Alexander B. Wiltschko
United States
United States
United States
HARANDI, SIAMAK
2021-10-1317500780VASOPRESSIN RECEPTOR ANTAGONISTS AND PRODUCTS AND METHODS RELATED THERETONeumora Therapeutics, Inc.Patented Case2024-01-0211858943US20230093235A1
Robert M. Jones
Mariangela Urbano
Gary Brandt
David Hardick
Chris Knight
Jason Tierney
United States
United States
United States
United Kingdom
United Kingdom
United Kingdom
MCMILLIAN, KARA RENITA
2021-09-0117446633MACHINE LEARNING-BASED DIAGNOSTIC CLASSIFIERNEUMORA THERAPEUTICS, INCPatented Case2023-06-1311676732US20210398685A1
Monika Sharma MELLEM
Yuelu LIU
Parvez AHAMMAD
Humberto Andres GONZALEZ CABEZAS
William J. MARTIN
Pablo Christian GERSBERG
United States
United States
United States
United States
United States
United States
TOMASZEWSKI, MICHAEL
2021-06-08173119741-(2,6-DIAZASPIRO[3.3]HEPTAN-6-YL)-5,6-DIHYDRO-4H-BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE DERIVATIVES AND RELATED COMPOUNDS AS VASOPRESSIN ANTAGONISTS FOR THE TREATMENT OF NEURO-PSYCHOLOGICAL DISORDERSNeumora Therapeutics, Inc.Patented Case2025-03-1112247037US20230084719A1
Gary Brandt
United States
CHENG, KAREN
2021-03-0517194069VASOPRESSIN RECEPTOR ANTAGONISTS AND PRODUCTS AND METHODS RELATED THERETONeumora Therapeutics, Inc.Patented Case2024-11-2612152038US20210317126A1
Robert M. Jones
Mariangela Urbano
Gary Brandt
Mark Chambers
David Hardick
Chris Knight
Jason Tierney
Chris Lock
United States
United States
United States
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
VALENROD, YEVGENY

Similar stocks

Stock NameCountryMarket CapPE Ratio
Armata Pharmaceuticals, Inc. (ARMP)United States$0.132B
Caribou Biosciences, Inc. (CRBU)United States$0.134B-1.79
enGene Therapeutics Inc. (ENGN)$0.129B-0.92
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
LENZ Therapeutics, Inc. (LENZ)United States$0.117B-1.41
Humacyte, Inc. (HUMA)United States$0.155B-2.26
Black Diamond Therapeutics, Inc. (BDTX)United States$0.109B-2.48
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22